Performa HargaHarga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)19.3
Harga Terendah (52 Minggu)14
Latar Belakang Perusahaan
Perusahaan bioteknologi yang mengembangkan terapi berbasis sel punca untuk pengobatan penyakit inflamasi dan kondisi medis serius lainnya.
Summary
Valuation Information
Current PE Ratio (TTM)-21.92
Forward PE Ratio454.55
Current Price to Book Value3.73
Current Price to Sales32.66
EV to Revenue31.63
EV to EBITDA-6.55
PEG Ratio-
Per Share
Current EPS (Annualized)-0.76
Diluted EPS (TTM)-0.76
Revenue Per Share0.51
Current Book Value Per Share4.46
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-64339000
Profit Margin-1.443
Operating Margin-0.552
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
